- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Gefitinib market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Gefitinib market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Gefitinib global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 10 Tables/Box segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Gefitinib include AstraZeneca, Qilu Pharmaceutical, Natco Pharma, Celon Laboratories, and Hetero Drugs, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Gefitinib market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
10 Tables/Box
30 Tables/Box
90 Tables/Box
Market segment by Application can be divided into
Hospital
Clinic
Drug Center
Other
The key market players for global Gefitinib market are listed below:
AstraZeneca
Qilu Pharmaceutical
Natco Pharma
Celon Laboratories
Hetero Drugs
Dr Reddy's Laboratories
Zuventus Healthcare
United Biotech
Panacea Biotec
Cipla
Glenmark Pharmaceuticals
Nobel Ilac Sanayii Ve Ticaret
Accure Labs
Cadila Pharmaceuticals
Ethypharm
Flagship Biotech International
Globela Pharma
Jodas Expoim
Nishchay Pharmaceuticals
Sichuan Xieli Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Gefitinib product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Gefitinib, with price, sales, revenue and global market share of Gefitinib from 2019 to 2022.
Chapter 3, the Gefitinib competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Gefitinib breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Gefitinib market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Gefitinib.
Chapter 13, 14, and 15, to describe Gefitinib sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Gefitinib Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Gefitinib Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 10 Tables/Box
1.2.3 30 Tables/Box
1.2.4 90 Tables/Box
1.3 Market Analysis by Application
1.3.1 Overview: Global Gefitinib Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Drug Center
1.3.5 Other
1.4 Global Gefitinib Market Size & Forecast
1.4.1 Global Gefitinib Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Gefitinib Sales in Volume (2017-2028)
1.4.3 Global Gefitinib Price (2017-2028)
1.5 Global Gefitinib Production Capacity Analysis
1.5.1 Global Gefitinib Total Production Capacity (2017-2028)
1.5.2 Global Gefitinib Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Gefitinib Market Drivers
1.6.2 Gefitinib Market Restraints
1.6.3 Gefitinib Trends Analysis
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business
2.1.3 AstraZeneca Gefitinib Product and Services
2.1.4 AstraZeneca Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Qilu Pharmaceutical
2.2.1 Qilu Pharmaceutical Details
2.2.2 Qilu Pharmaceutical Major Business
2.2.3 Qilu Pharmaceutical Gefitinib Product and Services
2.2.4 Qilu Pharmaceutical Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Natco Pharma
2.3.1 Natco Pharma Details
2.3.2 Natco Pharma Major Business
2.3.3 Natco Pharma Gefitinib Product and Services
2.3.4 Natco Pharma Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Celon Laboratories
2.4.1 Celon Laboratories Details
2.4.2 Celon Laboratories Major Business
2.4.3 Celon Laboratories Gefitinib Product and Services
2.4.4 Celon Laboratories Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Hetero Drugs
2.5.1 Hetero Drugs Details
2.5.2 Hetero Drugs Major Business
2.5.3 Hetero Drugs Gefitinib Product and Services
2.5.4 Hetero Drugs Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Dr Reddy's Laboratories
2.6.1 Dr Reddy's Laboratories Details
2.6.2 Dr Reddy's Laboratories Major Business
2.6.3 Dr Reddy's Laboratories Gefitinib Product and Services
2.6.4 Dr Reddy's Laboratories Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Zuventus Healthcare
2.7.1 Zuventus Healthcare Details
2.7.2 Zuventus Healthcare Major Business
2.7.3 Zuventus Healthcare Gefitinib Product and Services
2.7.4 Zuventus Healthcare Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 United Biotech
2.8.1 United Biotech Details
2.8.2 United Biotech Major Business
2.8.3 United Biotech Gefitinib Product and Services
2.8.4 United Biotech Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Panacea Biotec
2.9.1 Panacea Biotec Details
2.9.2 Panacea Biotec Major Business
2.9.3 Panacea Biotec Gefitinib Product and Services
2.9.4 Panacea Biotec Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Cipla
2.10.1 Cipla Details
2.10.2 Cipla Major Business
2.10.3 Cipla Gefitinib Product and Services
2.10.4 Cipla Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Glenmark Pharmaceuticals
2.11.1 Glenmark Pharmaceuticals Details
2.11.2 Glenmark Pharmaceuticals Major Business
2.11.3 Glenmark Pharmaceuticals Gefitinib Product and Services
2.11.4 Glenmark Pharmaceuticals Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Nobel Ilac Sanayii Ve Ticaret
2.12.1 Nobel Ilac Sanayii Ve Ticaret Details
2.12.2 Nobel Ilac Sanayii Ve Ticaret Major Business
2.12.3 Nobel Ilac Sanayii Ve Ticaret Gefitinib Product and Services
2.12.4 Nobel Ilac Sanayii Ve Ticaret Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Accure Labs
2.13.1 Accure Labs Details
2.13.2 Accure Labs Major Business
2.13.3 Accure Labs Gefitinib Product and Services
2.13.4 Accure Labs Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Cadila Pharmaceuticals
2.14.1 Cadila Pharmaceuticals Details
2.14.2 Cadila Pharmaceuticals Major Business
2.14.3 Cadila Pharmaceuticals Gefitinib Product and Services
2.14.4 Cadila Pharmaceuticals Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Ethypharm
2.15.1 Ethypharm Details
2.15.2 Ethypharm Major Business
2.15.3 Ethypharm Gefitinib Product and Services
2.15.4 Ethypharm Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Flagship Biotech International
2.16.1 Flagship Biotech International Details
2.16.2 Flagship Biotech International Major Business
2.16.3 Flagship Biotech International Gefitinib Product and Services
2.16.4 Flagship Biotech International Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Globela Pharma
2.17.1 Globela Pharma Details
2.17.2 Globela Pharma Major Business
2.17.3 Globela Pharma Gefitinib Product and Services
2.17.4 Globela Pharma Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 Jodas Expoim
2.18.1 Jodas Expoim Details
2.18.2 Jodas Expoim Major Business
2.18.3 Jodas Expoim Gefitinib Product and Services
2.18.4 Jodas Expoim Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19 Nishchay Pharmaceuticals
2.19.1 Nishchay Pharmaceuticals Details
2.19.2 Nishchay Pharmaceuticals Major Business
2.19.3 Nishchay Pharmaceuticals Gefitinib Product and Services
2.19.4 Nishchay Pharmaceuticals Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.20 Sichuan Xieli Pharmaceutical
2.20.1 Sichuan Xieli Pharmaceutical Details
2.20.2 Sichuan Xieli Pharmaceutical Major Business
2.20.3 Sichuan Xieli Pharmaceutical Gefitinib Product and Services
2.20.4 Sichuan Xieli Pharmaceutical Gefitinib Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Gefitinib Breakdown Data by Manufacturer
3.1 Global Gefitinib Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Gefitinib Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Gefitinib
3.4 Market Concentration Rate
3.4.1 Top 3 Gefitinib Manufacturer Market Share in 2021
3.4.2 Top 6 Gefitinib Manufacturer Market Share in 2021
3.5 Global Gefitinib Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Gefitinib Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Gefitinib Market Size by Region
4.1.1 Global Gefitinib Sales in Volume by Region (2017-2028)
4.1.2 Global Gefitinib Revenue by Region (2017-2028)
4.2 North America Gefitinib Revenue (2017-2028)
4.3 Europe Gefitinib Revenue (2017-2028)
4.4 Asia-Pacific Gefitinib Revenue (2017-2028)
4.5 South America Gefitinib Revenue (2017-2028)
4.6 Middle East and Africa Gefitinib Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Gefitinib Sales in Volume by Type (2017-2028)
5.2 Global Gefitinib Revenue by Type (2017-2028)
5.3 Global Gefitinib Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Gefitinib Sales in Volume by Application (2017-2028)
6.2 Global Gefitinib Revenue by Application (2017-2028)
6.3 Global Gefitinib Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Gefitinib Sales by Type (2017-2028)
7.2 North America Gefitinib Sales by Application (2017-2028)
7.3 North America Gefitinib Market Size by Country
7.3.1 North America Gefitinib Sales in Volume by Country (2017-2028)
7.3.2 North America Gefitinib Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Gefitinib Sales by Type (2017-2028)
8.2 Europe Gefitinib Sales by Application (2017-2028)
8.3 Europe Gefitinib Market Size by Country
8.3.1 Europe Gefitinib Sales in Volume by Country (2017-2028)
8.3.2 Europe Gefitinib Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Gefitinib Sales by Type (2017-2028)
9.2 Asia-Pacific Gefitinib Sales by Application (2017-2028)
9.3 Asia-Pacific Gefitinib Market Size by Region
9.3.1 Asia-Pacific Gefitinib Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Gefitinib Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Gefitinib Sales by Type (2017-2028)
10.2 South America Gefitinib Sales by Application (2017-2028)
10.3 South America Gefitinib Market Size by Country
10.3.1 South America Gefitinib Sales in Volume by Country (2017-2028)
10.3.2 South America Gefitinib Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Gefitinib Sales by Type (2017-2028)
11.2 Middle East & Africa Gefitinib Sales by Application (2017-2028)
11.3 Middle East & Africa Gefitinib Market Size by Country
11.3.1 Middle East & Africa Gefitinib Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Gefitinib Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Gefitinib and Key Manufacturers
12.2 Manufacturing Costs Percentage of Gefitinib
12.3 Gefitinib Production Process
12.4 Gefitinib Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Gefitinib Typical Distributors
13.3 Gefitinib Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Gefitinib Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Gefitinib Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 4. AstraZeneca Major Business
Table 5. AstraZeneca Gefitinib Product and Services
Table 6. AstraZeneca Gefitinib Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 8. Qilu Pharmaceutical Major Business
Table 9. Qilu Pharmaceutical Gefitinib Product and Services
Table 10. Qilu Pharmaceutical Gefitinib Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Natco Pharma Basic Information, Manufacturing Base and Competitors
Table 12. Natco Pharma Major Business
Table 13. Natco Pharma Gefitinib Product and Services
Table 14. Natco Pharma Gefitinib Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Celon Laboratories Basic Information, Manufacturing Base and Competitors
Table 16. Celon Laboratories Major Business
Table 17. Celon Laboratories Gefitinib Product and Services
Table 18. Celon Laboratories Gefitinib Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Hetero Drugs Basic Information, Manufacturing Base and Competitors
Table 20. Hetero Drugs Major Business
Table 21. Hetero Drugs Gefitinib Product and Services
Table 22. Hetero Drugs Gefitinib Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Dr Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table 24. Dr Reddy's Laboratories Major Business
Table 25. Dr Reddy's Laboratories Gefitinib Product and Services
Table 26. Dr Reddy's Laboratories Gefitinib Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Zuventus Healthcare Basic Information, Manufacturing Base and Competitors
Table 28. Zuventus Healthcare Major Business
Table 29. Zuventus Healthcare Gefitinib Product and Services
Table 30. Zuventus Healthcare Gefitinib Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. United Biotech Basic Information, Manufacturing Base and Competitors
Table 32. United Biotech Major Business
Table 33. United Biotech Gefitinib Product and Services
Table 34. United Biotech Gefitinib Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Panacea Biotec Basic Information, Manufacturing Base and Competitors
Table 36. Panacea Biotec Major Business
Table 37. Panacea Biotec Gefitinib Product and Services
Table 38. Panacea Biotec Gefitinib Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Cipla Basic Information, Manufacturing Base and Competitors
Table 40. Cipla Major Business
Table 41. Cipla Gefitinib Product and Services
Table 42. Cipla Gefitinib Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Glenmark Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 44. Glenmark Pharmaceuticals Major Business
Table 45. Glenmark Pharmaceuticals Gefitinib Product and Services
Table 46. Glenmark Pharmaceuticals Gefitinib Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Nobel Ilac Sanayii Ve Ticaret Basic Information, Manufacturing Base and Competitors
Table 48. Nobel Ilac Sanayii Ve Ticaret Major Business
Table 49. Nobel Ilac Sanayii Ve Ticaret Gefitinib Product and Services
Table 50. Nobel Ilac Sanayii Ve Ticaret Gefitinib Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Accure Labs Basic Information, Manufacturing Base and Competitors
Table 52. Accure Labs Major Business
Table 53. Accure Labs Gefitinib Product and Services
Table 54. Accure Labs Gefitinib Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Cadila Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 56. Cadila Pharmaceuticals Major Business
Table 57. Cadila Pharmaceuticals Gefitinib Product and Services
Table 58. Cadila Pharmaceuticals Gefitinib Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Ethypharm Basic Information, Manufacturing Base and Competitors
Table 60. Ethypharm Major Business
Table 61. Ethypharm Gefitinib Product and Services
Table 62. Ethypharm Gefitinib Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Flagship Biotech International Basic Information, Manufacturing Base and Competitors
Table 64. Flagship Biotech International Major Business
Table 65. Flagship Biotech International Gefitinib Product and Services
Table 66. Flagship Biotech International Gefitinib Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Globela Pharma Basic Information, Manufacturing Base and Competitors
Table 68. Globela Pharma Major Business
Table 69. Globela Pharma Gefitinib Product and Services
Table 70. Globela Pharma Gefitinib Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 71. Jodas Expoim Basic Information, Manufacturing Base and Competitors
Table 72. Jodas Expoim Major Business
Table 73. Jodas Expoim Gefitinib Product and Services
Table 74. Jodas Expoim Gefitinib Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 75. Nishchay Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 76. Nishchay Pharmaceuticals Major Business
Table 77. Nishchay Pharmaceuticals Gefitinib Product and Services
Table 78. Nishchay Pharmaceuticals Gefitinib Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 79. Sichuan Xieli Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 80. Sichuan Xieli Pharmaceutical Major Business
Table 81. Sichuan Xieli Pharmaceutical Gefitinib Product and Services
Table 82. Sichuan Xieli Pharmaceutical Gefitinib Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 83. Global Gefitinib Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Pcs)
Table 84. Global Gefitinib Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 85. Market Position of Manufacturers in Gefitinib, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 86. Global Gefitinib Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 87. Head Office and Gefitinib Production Site of Key Manufacturer
Table 88. Gefitinib New Entrant and Capacity Expansion Plans
Table 89. Gefitinib Mergers & Acquisitions in the Past Five Years
Table 90. Global Gefitinib Sales by Region (2017-2022) & (K Pcs)
Table 91. Global Gefitinib Sales by Region (2023-2028) & (K Pcs)
Table 92. Global Gefitinib Revenue by Region (2017-2022) & (USD Million)
Table 93. Global Gefitinib Revenue by Region (2023-2028) & (USD Million)
Table 94. Global Gefitinib Sales by Type (2017-2022) & (K Pcs)
Table 95. Global Gefitinib Sales by Type (2023-2028) & (K Pcs)
Table 96. Global Gefitinib Revenue by Type (2017-2022) & (USD Million)
Table 97. Global Gefitinib Revenue by Type (2023-2028) & (USD Million)
Table 98. Global Gefitinib Price by Type (2017-2022) & (USD/Pcs)
Table 99. Global Gefitinib Price by Type (2023-2028) & (USD/Pcs)
Table 100. Global Gefitinib Sales by Application (2017-2022) & (K Pcs)
Table 101. Global Gefitinib Sales by Application (2023-2028) & (K Pcs)
Table 102. Global Gefitinib Revenue by Application (2017-2022) & (USD Million)
Table 103. Global Gefitinib Revenue by Application (2023-2028) & (USD Million)
Table 104. Global Gefitinib Price by Application (2017-2022) & (USD/Pcs)
Table 105. Global Gefitinib Price by Application (2023-2028) & (USD/Pcs)
Table 106. North America Gefitinib Sales by Country (2017-2022) & (K Pcs)
Table 107. North America Gefitinib Sales by Country (2023-2028) & (K Pcs)
Table 108. North America Gefitinib Revenue by Country (2017-2022) & (USD Million)
Table 109. North America Gefitinib Revenue by Country (2023-2028) & (USD Million)
Table 110. North America Gefitinib Sales by Type (2017-2022) & (K Pcs)
Table 111. North America Gefitinib Sales by Type (2023-2028) & (K Pcs)
Table 112. North America Gefitinib Sales by Application (2017-2022) & (K Pcs)
Table 113. North America Gefitinib Sales by Application (2023-2028) & (K Pcs)
Table 114. Europe Gefitinib Sales by Country (2017-2022) & (K Pcs)
Table 115. Europe Gefitinib Sales by Country (2023-2028) & (K Pcs)
Table 116. Europe Gefitinib Revenue by Country (2017-2022) & (USD Million)
Table 117. Europe Gefitinib Revenue by Country (2023-2028) & (USD Million)
Table 118. Europe Gefitinib Sales by Type (2017-2022) & (K Pcs)
Table 119. Europe Gefitinib Sales by Type (2023-2028) & (K Pcs)
Table 120. Europe Gefitinib Sales by Application (2017-2022) & (K Pcs)
Table 121. Europe Gefitinib Sales by Application (2023-2028) & (K Pcs)
Table 122. Asia-Pacific Gefitinib Sales by Region (2017-2022) & (K Pcs)
Table 123. Asia-Pacific Gefitinib Sales by Region (2023-2028) & (K Pcs)
Table 124. Asia-Pacific Gefitinib Revenue by Region (2017-2022) & (USD Million)
Table 125. Asia-Pacific Gefitinib Revenue by Region (2023-2028) & (USD Million)
Table 126. Asia-Pacific Gefitinib Sales by Type (2017-2022) & (K Pcs)
Table 127. Asia-Pacific Gefitinib Sales by Type (2023-2028) & (K Pcs)
Table 128. Asia-Pacific Gefitinib Sales by Application (2017-2022) & (K Pcs)
Table 129. Asia-Pacific Gefitinib Sales by Application (2023-2028) & (K Pcs)
Table 130. South America Gefitinib Sales by Country (2017-2022) & (K Pcs)
Table 131. South America Gefitinib Sales by Country (2023-2028) & (K Pcs)
Table 132. South America Gefitinib Revenue by Country (2017-2022) & (USD Million)
Table 133. South America Gefitinib Revenue by Country (2023-2028) & (USD Million)
Table 134. South America Gefitinib Sales by Type (2017-2022) & (K Pcs)
Table 135. South America Gefitinib Sales by Type (2023-2028) & (K Pcs)
Table 136. South America Gefitinib Sales by Application (2017-2022) & (K Pcs)
Table 137. South America Gefitinib Sales by Application (2023-2028) & (K Pcs)
Table 138. Middle East & Africa Gefitinib Sales by Region (2017-2022) & (K Pcs)
Table 139. Middle East & Africa Gefitinib Sales by Region (2023-2028) & (K Pcs)
Table 140. Middle East & Africa Gefitinib Revenue by Region (2017-2022) & (USD Million)
Table 141. Middle East & Africa Gefitinib Revenue by Region (2023-2028) & (USD Million)
Table 142. Middle East & Africa Gefitinib Sales by Type (2017-2022) & (K Pcs)
Table 143. Middle East & Africa Gefitinib Sales by Type (2023-2028) & (K Pcs)
Table 144. Middle East & Africa Gefitinib Sales by Application (2017-2022) & (K Pcs)
Table 145. Middle East & Africa Gefitinib Sales by Application (2023-2028) & (K Pcs)
Table 146. Gefitinib Raw Material
Table 147. Key Manufacturers of Gefitinib Raw Materials
Table 148. Direct Channel Pros & Cons
Table 149. Indirect Channel Pros & Cons
Table 150. Gefitinib Typical Distributors
Table 151. Gefitinib Typical Customers
List of Figures
Figure 1. Gefitinib Picture
Figure 2. Global Gefitinib Revenue Market Share by Type in 2021
Figure 3. 10 Tables/Box
Figure 4. 30 Tables/Box
Figure 5. 90 Tables/Box
Figure 6. Global Gefitinib Revenue Market Share by Application in 2021
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Drug Center
Figure 10. Other
Figure 11. Global Gefitinib Revenue, (USD Million) & (K Pcs): 2017 & 2021 & 2028
Figure 12. Global Gefitinib Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Gefitinib Sales (2017-2028) & (K Pcs)
Figure 14. Global Gefitinib Price (2017-2028) & (USD/Pcs)
Figure 15. Global Gefitinib Production Capacity (2017-2028) & (K Pcs)
Figure 16. Global Gefitinib Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Gefitinib Market Drivers
Figure 18. Gefitinib Market Restraints
Figure 19. Gefitinib Market Trends
Figure 20. Global Gefitinib Sales Market Share by Manufacturer in 2021
Figure 21. Global Gefitinib Revenue Market Share by Manufacturer in 2021
Figure 22. Gefitinib Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Gefitinib Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Gefitinib Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Gefitinib Sales Market Share by Region (2017-2028)
Figure 26. Global Gefitinib Revenue Market Share by Region (2017-2028)
Figure 27. North America Gefitinib Revenue (2017-2028) & (USD Million)
Figure 28. Europe Gefitinib Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Gefitinib Revenue (2017-2028) & (USD Million)
Figure 30. South America Gefitinib Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Gefitinib Revenue (2017-2028) & (USD Million)
Figure 32. Global Gefitinib Sales Market Share by Type (2017-2028)
Figure 33. Global Gefitinib Revenue Market Share by Type (2017-2028)
Figure 34. Global Gefitinib Price by Type (2017-2028) & (USD/Pcs)
Figure 35. Global Gefitinib Sales Market Share by Application (2017-2028)
Figure 36. Global Gefitinib Revenue Market Share by Application (2017-2028)
Figure 37. Global Gefitinib Price by Application (2017-2028) & (USD/Pcs)
Figure 38. North America Gefitinib Sales Market Share by Type (2017-2028)
Figure 39. North America Gefitinib Sales Market Share by Application (2017-2028)
Figure 40. North America Gefitinib Sales Market Share by Country (2017-2028)
Figure 41. North America Gefitinib Revenue Market Share by Country (2017-2028)
Figure 42. United States Gefitinib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Gefitinib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Gefitinib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Gefitinib Sales Market Share by Type (2017-2028)
Figure 46. Europe Gefitinib Sales Market Share by Application (2017-2028)
Figure 47. Europe Gefitinib Sales Market Share by Country (2017-2028)
Figure 48. Europe Gefitinib Revenue Market Share by Country (2017-2028)
Figure 49. Germany Gefitinib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Gefitinib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Gefitinib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Gefitinib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Gefitinib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Gefitinib Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Gefitinib Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Gefitinib Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Gefitinib Revenue Market Share by Region (2017-2028)
Figure 58. China Gefitinib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Gefitinib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Gefitinib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Gefitinib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Gefitinib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Gefitinib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Gefitinib Sales Market Share by Type (2017-2028)
Figure 65. South America Gefitinib Sales Market Share by Application (2017-2028)
Figure 66. South America Gefitinib Sales Market Share by Country (2017-2028)
Figure 67. South America Gefitinib Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Gefitinib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Gefitinib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Gefitinib Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Gefitinib Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Gefitinib Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Gefitinib Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Gefitinib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Gefitinib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Gefitinib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Gefitinib Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Gefitinib in 2021
Figure 79. Manufacturing Process Analysis of Gefitinib
Figure 80. Gefitinib Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
